Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,040,344 |
|
|||||
| News | - | ||||||
| Day High | 754.72 | Low High |
|||||
| Day Low | 728.785 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | LLY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -14.26 | -1.91% | 731.43 | 12:53:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 752.64 | 728.785 | 754.72 | 745.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 45,873 | 1,040,344 | $ 740.79 | $ 770,672,530 | - | 370.68 - 800.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:53:21 | 10 | $ 731.4392 | USD |
Eli Lilly (LLY) Options Flow Summary
Eli Lilly and Co Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 694.26B | 950.16M | - | 34.12B | 5.24B | 5.52 | 132.48 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eli Lilly News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 760.96 | 771.83 | 722.07 | 738.93 | 2,534,778 | -29.53 | -3.88% |
| 1 Month | 778.90 | 793.67 | 722.07 | 758.06 | 2,422,334 | -47.47 | -6.09% |
| 3 Months | 650.38 | 800.78 | 637.00 | 749.11 | 3,116,010 | 81.05 | 12.46% |
| 6 Months | 579.45 | 800.78 | 547.61 | 668.48 | 3,096,013 | 151.98 | 26.23% |
| 1 Year | 385.15 | 800.78 | 370.68 | 582.04 | 3,050,836 | 346.28 | 89.91% |
| 3 Years | 188.57 | 800.78 | 178.5779 | 387.41 | 2,998,293 | 542.86 | 287.88% |
| 5 Years | 118.04 | 800.78 | 101.36 | 274.90 | 3,333,617 | 613.39 | 519.65% |
Eli Lilly Description
| Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. |
